↓ Skip to main content

Monocyte programmed death ligand-1 expression is an early marker for predicting infectious complications in acute pancreatitis

Overview of attention for article published in Critical Care, July 2017
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (62nd percentile)

Mentioned by

twitter
8 X users

Citations

dimensions_citation
37 Dimensions

Readers on

mendeley
33 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Monocyte programmed death ligand-1 expression is an early marker for predicting infectious complications in acute pancreatitis
Published in
Critical Care, July 2017
DOI 10.1186/s13054-017-1781-3
Pubmed ID
Authors

Tingting Pan, Tianyun Zhou, Lei Li, Zhaojun Liu, Ying Chen, Enqiang Mao, Meiling Li, Hongping Qu, Jialin Liu

Abstract

Acute pancreatitis (AP) is a life-threatening disease that requires early identification of patients at risk of developing infectious complications. Immunosuppression is an initial event that is key to AP pathogenesis. The programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) system is reported to mediate evasion of host immune surveillance in many diseases; however, the relationship between PD-1/PD-L1 expression and these parameters or infectious complications in AP has not been elucidated. This study was conducted to determine whether PD-1 and PD-L1 are upregulated and to reveal the relationship between PD-1/PD-L1 expression and the development of infectious complications in AP. Sixty-three patients with AP and 32 sex- and age-matched healthy control subjects were prospectively enrolled. On days 1 and 3 after the onset of AP, we measured PD-1 expression in peripheral CD4(+) T cells and PD-L1 and human leukocyte antigen-DR (HLA-DR) expression in CD14(+) monocytes using flow cytometry. Plasma interleukin (IL)-10 levels were measured by enzyme-linked immunosorbent assay. Compared with healthy volunteers, the percentages of PD-1-expressing CD4(+) lymphocytes and PD-L1-expressing CD14(+) monocytes were increased in patients with AP on days 1 and 3 after onset, especially those with infectious complications. Moreover, increased PD-1/PD-L1 expression was associated with increased occurrence of infectious complications, decreased circulating lymphocytes, and increased plasma IL-10 concentration. Multivariate regression analysis indicated that the increased percentage of PD-L1-expressing CD14(+) monocytes was an independent risk factor for infectious complications in AP. Area under the ROC curve analysis showed the combination of Acute Physiology and Chronic Health Evaluation II score and PD-L1 and HLA-DR expression in CD14(+) monocytes had high accuracy in predicting infectious complications in patients with AP. The PD-1/PD-L1 system plays an essential role in the early immunosuppression of AP. PD-L1 expression in CD14(+) monocytes may be a new marker for predicting risk of infectious complications in patients with AP.

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 33 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 21%
Researcher 6 18%
Student > Master 4 12%
Student > Bachelor 3 9%
Student > Doctoral Student 2 6%
Other 0 0%
Unknown 11 33%
Readers by discipline Count As %
Medicine and Dentistry 13 39%
Biochemistry, Genetics and Molecular Biology 3 9%
Immunology and Microbiology 2 6%
Agricultural and Biological Sciences 1 3%
Nursing and Health Professions 1 3%
Other 1 3%
Unknown 12 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 July 2017.
All research outputs
#7,711,857
of 23,978,545 outputs
Outputs from Critical Care
#4,085
of 6,283 outputs
Outputs of similar age
#116,785
of 315,498 outputs
Outputs of similar age from Critical Care
#91
of 105 outputs
Altmetric has tracked 23,978,545 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 6,283 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.3. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 315,498 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.
We're also able to compare this research output to 105 others from the same source and published within six weeks on either side of this one. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.